These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11927075)

  • 21. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility.
    Bush KA; McAnulty J; McPhie K; Reynolds R; Boomer M; Clarkson LM; Quaine J; Dwyer DE;
    Commun Dis Intell Q Rep; 2004; 28(3):396-400. PubMed ID: 15574064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F
    Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The threatening influenza pandemic: a national store of oseltamivir is necessary].
    de Jong JC; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1618. PubMed ID: 16078768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
    Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocontainment. 1918 flu experiments spark concerns about biosafety.
    Kaiser J
    Science; 2004 Oct; 306(5696):591. PubMed ID: 15498981
    [No Abstract]   [Full Text] [Related]  

  • 29. [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients].
    Deng WW; Li QY; Zhong NS;
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2132-6. PubMed ID: 15730636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [English meta-analysis on zanamivir and oseltamivir. Knowledge of effects of influenza agents still not sufficient].
    Liedholm H
    Lakartidningen; 2003 Dec; 100(50):4186-9. PubMed ID: 14717007
    [No Abstract]   [Full Text] [Related]  

  • 31. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
    Ward P; Small I; Smith J; Suter P; Dutkowski R
    J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and control of influenza outbreaks in well-vaccinated nursing home populations.
    Monto AS; Rotthoff J; Teich E; Herlocher ML; Truscon R; Yen HL; Elias S; Ohmit SE
    Clin Infect Dis; 2004 Aug; 39(4):459-64. PubMed ID: 15356805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 Jun; 32(ACS-7):1-27. PubMed ID: 16805064
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Jun; 31(ACS-6):1-30. PubMed ID: 15959943
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000.
    Bowles SK; Lee W; Simor AE; Vearncombe M; Loeb M; Tamblyn S; Fearon M; Li Y; McGeer A;
    J Am Geriatr Soc; 2002 Apr; 50(4):608-16. PubMed ID: 11982659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults.
    Desbiens NA
    Am J Infect Control; 2005 May; 33(4):238-42. PubMed ID: 15877020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.